Rikke Borg

Translating the A1C Assay Into Estimated Average Glucose Values

David M. Nathan, J.C. Kuenen, Rikke Borg et al. · Diabetes Care · 2008 · 1.8K citations · Full text

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

Hiddo J.L. Heerspink, C. David Sjöström, Niels Jongs et al. · European Heart Journal · 2021 · 118 citations · Full text

Associations Between Features of Glucose Exposure and A1C

Rikke Borg, J.C. Kuenen, Bendix Carstensen et al. · Diabetes · 2010 · 93 citations · Full text

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Hiddo J.L. Heerspink, David Z.I. Cherney, Douwe Postmus et al. · Kidney International · 2021 · 92 citations · Full text

Does Glucose Variability Influence the Relationship Between Mean Plasma Glucose and HbA1c Levels in Type 1 and Type 2 Diabetic Patients?

J.C. Kuenen, Rikke Borg, Dirk J. Kuik et al. · Diabetes Care · 2011 · 90 citations · Full text